Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Comparison of the Efficacy and Safety of Risperidone Versus Risperidone Plus Low Dose of Haloperidol in the Treatment of Schizophrenia

This study has been terminated.
(terminated)
Sponsor:
Information provided by:
Kaohsiung Kai-Suan Psychiatric Hospital
ClinicalTrials.gov Identifier:
NCT00998608
First received: October 8, 2009
Last updated: October 18, 2009
Last verified: October 2009